These results as well as those of our present study indicate that patients with relatively abundant CTLs infiltrating in the tumor could have the potential to induce PD‐L1 in carcinoma cells even if the primary tumor had relatively low PD‐L1 status in carcinoma cells. The gene discussed is CD274; the disease is neoplasm.